Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

被引：0
|
作者：
Stefan Knop
Maria-Victoria Mateos
Meletios A. Dimopoulos
Kenshi Suzuki
Andrzej Jakubowiak
Chantal Doyen
Paulo Lucio
Zsolt Nagy
Ganna Usenko
Ludek Pour
Mark Cook
Sebastian Grosicki
Andre Crepaldi
Anna Marina Liberati
Philip Campbell
Tatiana Shelekhova
Sung-Soo Yoon
Genadi Losava
Tomoaki Fujisaki
Mamta Garg
Jianping Wang
Susan Wroblewski
Anupa Kudva
Katharine S. Gries
John Fastenau
Jesus San-Miguel
Michele Cavo
机构：
[1] Würzburg University Medical Center,Department of Haematology and Oncology
[2] University Hospital of Salamanca–Instituto de Investigación Biomédica de Salamanca,Department of Internal Medicine
[3] National and Kapodistrian University of Athens,Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine
[4] Japanese Red Cross Medical Center,undefined
[5] University of Chicago Medical Center,undefined
[6] Université Catholique of Louvain,undefined
[7] CHU UCL Namur,undefined
[8] Champalimaud Centre for the Unknown,undefined
[9] Semmelweis University,undefined
[10] Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4,undefined
[11] University Hospital Brno,undefined
[12] University Hospitals Birmingham NHS Trust,undefined
[13] Silesian Medical University,undefined
[14] Clinica de Tratamento E,undefined
[15] Azienda Ospedaliera “Santa Maria”,undefined
[16] Andrew Love Cancer Centre,undefined
[17] Clinic of Professional Pathology,undefined
[18] Seoul National University College of Medicine,undefined
[19] LTD “Medinvent” Institute of Health,undefined
[20] Matsuyama Red Cross Hospital,undefined
[21] Leicester Royal Infirmary,undefined
[22] Janssen Research and Development,undefined
[23] Janssen Research & Development,undefined
[24] LLC,undefined
[25] Clínica Universidad de Navarra–Centro de Investigación Médica Aplicada,undefined
[26] Instituto de Investigación Sanitaria de Navarra,undefined
[27] Centro de Investigación Biomédica en Red de Cáncer,undefined
[28] University of Bologna,undefined
来源：
BMC Cancer | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP): RESULTS FROM THE VISTA TRIAL
    Meunier, J.
    Regnault, A.
    Robinson, D.
    Rosa, K.
    San Miguel, J. F.
    van de Velde, H.
    Richardson, P. G.
    Cakana, A.
    Dhawan, R.
    VALUE IN HEALTH, 2009, 12 (07) : A284 - A284
  • [32] The Impact of Lenalidomide, Bortezomib, and Dexamethasone Treatment on Health-Related Quality of Life in Transplant-Eligible Patients with Newly-Diagnosed Multiple Myeloma: Results from the IFM/DFCI 2009 Trial
    Roussel, Murielle
    Hebraud, Benjamin
    Hulin, Cyrille
    Perrot, Aurore
    Caillot, Denis
    Macro, Margaret
    Arnulf, Bertrand
    Belhadj, Karim
    Garderet, Laurent
    Facon, Thierry
    Guo, Shien
    Altincatal, Arman
    Dhanasiri, Sujith
    Leleu, Xavier
    Moreau, Philippe
    Attal, Michel
    BLOOD, 2018, 132
  • [33] Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results
    Morgan, Gareth J.
    Davies, Faith E.
    Gregory, Walter M.
    Bell, Sue E.
    Szubert, Alexander J.
    Coy, Nuria Navarro
    Cook, Gordon
    Feyler, Sylvia
    Johnson, Peter R. E.
    Rudin, Claudius
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Russell, Nigel H.
    Jackson, Graham H.
    Child, J. Anthony
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 442 - 450
  • [34] Evaluation of the health-related quality of life of hematopoietic stem cell transplantation patients
    Tostes dos Santos, Carla Libralli
    Sawada, Namie Okino
    Ferreira dos Santos, Jair Licio
    REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2011, 19 (06): : 1322 - 1328
  • [35] Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Any or Lenalidomide Maintenance after Autologous Stem Cell Transplant in the Connect MM Disease Registry
    Abonour, Rafat
    Durie, Brian G. M.
    Jagannath, Sundar
    Shah, Jatin J.
    Narang, Mohit
    Terebelo, Howard R.
    Gasparetto, Cristina J.
    Toomey, Kathleen
    Hardin, James W.
    Kitali, Amani
    Gibson, Craig
    Srinivasan, Shankar
    Swern, Arlene S.
    Rifkin, Robert M.
    BLOOD, 2016, 128 (22)
  • [36] Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
    Dimopoulos, Meletios A.
    Spicka, Ivan
    Quach, Hang
    Oriol, Albert
    Hajek, Roman
    Garg, Mamta
    Beksac, Meral
    Bringhen, Sara
    Katodritou, Eirini
    Chng, Wee-Joo
    Leleu, Xavier
    Iida, Shinsuke
    Mateos, Maria-Victoria
    Morgan, Gareth
    Vorog, Alexander
    Labotka, Richard
    Wang, Bingxia
    Palumbo, Antonio
    Lonial, Sagar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34) : 4030 - 4041
  • [37] Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data
    Sandecka, Viera
    Pour, Ludek
    Spicka, Ivan
    Minarik, Jiri
    Radocha, Jakub
    Jelinek, Tomas
    Heindorfer, Adriana
    Pavlicek, Petr
    Sykora, Michal
    Jungova, Alexandra
    Kessler, Petr
    Wrobel, Marek
    Starostka, David
    Ullrychova, Jana
    Stejskal, Lukas
    Stork, Martin
    Straub, Jan
    Pika, Tomas
    Brozova, Lucie
    Sevcikova, Sabina
    Maisnar, Vladimir
    Hajek, Roman
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (04) : 466 - 474
  • [38] Real-life experience of the combination of daratumumab, bortezomib, melphalan, and prednisone (DVMP) in patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation
    Domingo-Gonzalez, Amalia
    Alonso, Rafael
    de Soto Alvarez, Teresa
    Lerma, Ana
    Martin Moro, Fernando
    Sanchez-Pina, Jose
    Pradillo Fernandez, Virginia
    Landete, Elena
    Velasco Valdazo, Alberto E.
    Menendez Cuevas, Marina
    Lopez Rinon, Monica Maria
    Ramirez Lopez, Andres
    Lopez-Garcia, Alberto
    Lazaro del Campo, Paula
    Ruiz Gomez, Fabio Augusto
    Jesus Blanchard, Maria
    Askari, Elham
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S144 - S144
  • [39] Indian multicentre phase II randomized study comparing post stem cell transplantation maintenance regimens for newly diagnosed multiple myeloma patients (IMPOSe trial)
    Yanamandra, Uday
    Ahuja, Ankur
    Kapoor, Rajan
    Das, Satyaranjan
    Pramanik, Suman
    Mishra, Kundan
    Kumar, Rajiv
    Khurana, Harshit
    Sharma, Sanjeevan
    Nair, Velu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S54 - S54
  • [40] The Relationship of Response on Time to Next Treatment Based on Evidence from Two RCTs in Newly Diagnosed Stem Cell Transplantation Ineligible Multiple Myeloma Patients
    Van Beurden-Tan, Chrissy H. Y.
    Blommestein, Hedwig
    Zweegman, Sonja
    Sonneveld, Pieter
    BLOOD, 2016, 128 (22)
12345